-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GgXiE2YSGnsteUD7+Qw9CAj0oxqxCvolby3FJbjW4X2ST/AmVAQjYRhS+lzkEwRs 6VrYxCIrQl0NaywFKroZyA== 0000912057-02-032226.txt : 20020814 0000912057-02-032226.hdr.sgml : 20020814 20020814180610 ACCESSION NUMBER: 0000912057-02-032226 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20020814 ITEM INFORMATION: Financial statements and exhibits ITEM INFORMATION: FILED AS OF DATE: 20020814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSGENOMIC INC CENTRAL INDEX KEY: 0001043961 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 911789357 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-30975 FILM NUMBER: 02737930 BUSINESS ADDRESS: STREET 1: 12325 EMMET ST CITY: OMAHA STATE: NE ZIP: 68164 BUSINESS PHONE: 4027385480 MAIL ADDRESS: STREET 1: 12325 EMMET STREET CITY: OMAHA STATE: NE ZIP: 68164 8-K 1 a2087082z8-k.htm 8-K
QuickLinks -- Click here to rapidly navigate through this document

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 14, 2002

TRANSGENOMIC, INC.
(Exact name of registrant as specified in its charter)

Delaware
(State of Formation)		   000-30975
(Commission File Number)

911789357
(IRS Employer Identification Number)

12325 Emmet Street
 
 
Omaha, NE   68164
(Address of principal executive offices)   (Zip Code)

(402) 452-5400
(Registrants' telephone number, including area code)

Not applicable
(Former name or former address, if changed since last report)


Item 7.    Financial Statements and Exhibits.

    (c)
    Exhibits.

    99.1
    Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, dated August 14, 2002.

    99.2
    Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, dated August 14, 2002.


Item 9.    Regulation FD Disclosure

        On August 14, 2002, the Registrant submitted its Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350 and its Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350 as correspondence to the Securities and Exchange Commission accompanying its Form 10-Q filed on August 14, 2002.

    Limitation on Incorporation by Reference

        In accordance with general instruction B.2 of Form 8-K, the information in this report is furnished pursuant to Item 9 and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section.

2


SIGNATURE

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    TRANSGENOMIC, INC.

 
 
By:
 
/s/  GREGORY J. DUMAN      
       
Gregory J. Duman
 Chief Financial Officer

August 14, 2002

3



QuickLinks

SIGNATURE
 EX-99.1 3 a2087082zex-99_1.htm EXHIBIT 99.1
QuickLinks -- Click here to rapidly navigate through this document


Exhibit 99.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350

        In connection with the accompanying Quarterly Report on Form 10-Q of Transgenomic, Inc. for the quarter ended June 30, 2002, I, Collin J. D'Silva, Chairman of the Board, President and Chief Executive Officer of Transgenomic, Inc., hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:

            (1)  such Quarterly Report on Form 10-Q of Transgenomic, Inc. for the quarter ended June 30, 2002, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

            (2)  the information contained in such Quarterly Report on Form 10-Q of Transgenomic, Inc. for the quarter ended June 30, 2002, fairly presents, in all material respects, the financial condition and results of operations of Transgenomic, Inc..

    /s/  COLLIN J. D'SILVA      
Collin J. D'Silva
 Chairman of the Board, President and Chief Executive Officer

Date: August 14, 2002



QuickLinks

 EX-99.2 4 a2087082zex-99_2.htm EXHIBIT 99.2
QuickLinks -- Click here to rapidly navigate through this document


Exhibit 99.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350

        In connection with the accompanying Quarterly Report on Form 10-Q of Transgenomic, Inc. for the quarter ended June 30, 2002, I, Gregory J. Duman, Chief Financial Officer and Executive Vice President of Transgenomic, Inc., hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:

            (1)  such Quarterly Report on Form 10-Q of Transgenomic, Inc. for the quarter ended June 30, 2002, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

            (2)  the information contained in such Quarterly Report on Form 10-Q of Transgenomic, Inc. for the quarter ended June 30, 2002, fairly presents, in all material respects, the financial condition and results of operations of Transgenomic, Inc..

    /s/  GREGORY J. DUMAN      
Gregory J. Duman
 Chief Financial Officer and Executive Vice President

Date: August 14, 2002




QuickLinks

 -----END PRIVACY-ENHANCED MESSAGE-----